Other Streptococcus spp.
ENT, Opthalmology, ID and/or relevant subspecialty team(s) if required
Before starting antimicrobial therapy, take blood/urine/CSF and/or other relevant samples for culture wherever possible.
Consider the need for dose adjustments (e.g. renal impairment) and age-related contraindications for antimicrobials.
Cefotaxime may be interchanged with ceftriaxone for children over 30 days old and not on calcium-containing parenteral products (e.g. TPN).
As anti-MRSA agent (current local MRSA rates are available via the hospital antibiogram)
Adjust treatment according to microbiologic results as soon as they become available.
MRSA Risk Factors
The following factors have been associated with MRSA in previous studies:
Previous known MRSA infection in child or a significant contact (e.g. family member)
Family member is a healthcare worker
First nations child or Pacific Island origin (e.g. Samoan)
Day care attendance
Prolonged hospitalization in the last 1 year
Antibiotic therapy in the last 2 months
Chronic skin condition (e.g. atopic eczema)